高表达的PTPN1促进了人类肝细胞癌中的瘤扩散特征
Liping Xie1, Huimin Qi2, Wenxiu Tian2
1Beijing Hospital of Integrated Traditional Chinese and Western Medicine, 100039, Beijing, China.
Heliyon
|October 9, 2023
概括
蛋白氨酸酸酶非受体1型 (PTPN1) 在肝癌 (HCC) 中被上调,并与预后不佳有关. 沉默PTPN1通过破坏细胞循环来抑制HCC细胞的增殖和迁移,这表明PTPN1是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 由于高发病率和死亡率,给全球健康带来了重大挑战.
- 目前的诊断方法为HCC患者的生存率提供了有限的改善,需要新的治疗目标.
- 蛋白氨酸酸酶 (PTPs) 是通过脱化来调节细胞信号通路的关键调节者.
研究的目的:
- 研究蛋白氨酸酸酶非受体1型 (PTPN1) 在肝细胞癌的发展和进展中的作用.
- 确定PTPN1作为HCC诊断和治疗的潜在分子标.
主要方法:
- 在HCC组织中分析PTPN1表达水平.
- 功能性研究涉及PTPN1沉默在HCC细胞系.
- 评估PTPN1操纵后的细胞周期进展,增殖和迁移.
主要成果:
- 在HCC中,PTPN1被上调,与患者预后不佳相关.
- 改变PTPN1表达会破坏HCC细胞的细胞周期进展和新陈代谢.
- 抑制PTPN1显著降低HCC细胞的增殖和迁移,阻断G1到S阶段的过渡.
结论:
- 通过干扰细胞循环调节,PTPN1在促进HCC发病和进展方面发挥着关键作用.
- PTPN1代表了一个有前途的分子标,用于开发肝癌的新型诊断和治疗策略.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


